US Stock MarketDetailed Quotes

CDTX Cidara Therapeutics

Watchlist
  • 20.2100
  • +0.0100+0.05%
Close Nov 29 13:00 ET
  • 20.2100
  • 0.00000.00%
Post 17:01 ET
221.08MMarket Cap-872P/E (TTM)

Cidara Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Cidara Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 300.000K--
--2024/Q30.000 / 433.330K--
--2024/Q2302.000K / 1.300M--
--2024/Q18.463M / 9.033M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 300.000K--
--2024/Q30.000 / 433.330K--
--2024/Q2302.000K / 1.300M--
--2024/Q18.463M / 9.033M--

Unlock Free Earnings Estimates

Cidara Therapeutics Earnings Reports

  • Cidara Therapeutics | 8-K: Cidara Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results

    Nov 7 22:36 ET

  • Cidara Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 7 16:15 ET

  • Cidara Therapeutics | 8-K: Cidara Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results

    Aug 13 16:24 ET

  • Cidara Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 13 16:19 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 30, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data